Herpes Simplex Virus Type 2 ICP47 Inhibits Human TAP but Not Mouse TAP
AUTOR(ES)
Tomazin, Roman
FONTE
American Society for Microbiology
RESUMO
Herpes simplex virus serotype 1 (HSV-1) expresses an immediate-early protein, ICP47, that effectively blocks the major histocompatibility complex class I antigen presentation pathway. HSV-1 ICP47 (ICP47-1) binds with high affinity to the human transporter associated with antigen presentation (TAP) and blocks the binding of antigenic peptides. HSV type 2 (HSV-2) ICP47 (ICP47-2) has only 42% amino acid sequence identity with ICP47-1. Here, we compared the levels of inhibition of human and murine TAP, expressed in insect cell microsomes, by ICP47-1 and ICP47-2. Both proteins inhibited human TAP at similar concentrations, and the KD for ICP47-2 binding to human TAP was 4.8 × 10−8 M, virtually identical to that measured for ICP47-1 (5.2 × 10−8 M). There was some inhibition of murine TAP by both ICP47-2 and ICP47-1, but this inhibition was incomplete and only at ICP47 concentrations 50 to 100 times that required to inhibit human TAP. Lack of inhibition of murine TAP by ICP47-1 and ICP47-2 could be explained by an inability of both proteins to bind to murine TAP.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=109564Documentos Relacionados
- Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.
- Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47
- Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.
- Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.
- Expression of Herpes Simplex Virus ICP47 and Human Cytomegalovirus US11 Prevents Recognition of Transgene Products by CD8+ Cytotoxic T Lymphocytes